PATP1280.01 – Neurophorol™ AI-Assisted Technical Review

At Biotech International Institute, Neurophorol™ is framed as a research-stage, patent-pending investigational platform built around a differentiated xanthene-core cannabinoid architecture and a CB2-selective design strategy.

Our new public-facing summary page is designed to make the platform easier to understand from a scientific and technical perspective, including:

  • structural novelty

  • receptor selectivity logic

  • research-stage development focus

  • formulation and manufacturing direction

  • translational review context

The open page is intended for visibility, clarity, and better scientific communication.

More detailed AI-assisted technical review materials will be available to qualified parties under NDA / CDA.

ai-assisted-tech-review-of-neurophoral

Research-stage. Patent-pending. Built for validation.

Mechanism first. Validation always.

Next
Next

PATP1280.04 – Mycophorol™ AI-Assisted Technical Review